Evaluation of performance of Dutch newborn screening program for cystic fibrosis (2016-2020)
M. Bouva (Bilthoven, Netherlands), K. Van Der Ploeg (Leiden, Netherlands), R. Verschoof - Puite (Bilthoven, Netherlands), V. Gulmans (Baarn, Netherlands), J. Gille (Amsterdam, Netherlands), B. Jakobs (Tilburg, Netherlands), M. Heijnen (Bilthoven, Netherlands), K. De Winter - De Groot (Utrecht, Netherlands)
Source: International Congress 2022 – Cystic fibrosis in children and adolescents
Session: Cystic fibrosis in children and adolescents
Session type: Thematic Poster
Number: 295
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Bouva (Bilthoven, Netherlands), K. Van Der Ploeg (Leiden, Netherlands), R. Verschoof - Puite (Bilthoven, Netherlands), V. Gulmans (Baarn, Netherlands), J. Gille (Amsterdam, Netherlands), B. Jakobs (Tilburg, Netherlands), M. Heijnen (Bilthoven, Netherlands), K. De Winter - De Groot (Utrecht, Netherlands). Evaluation of performance of Dutch newborn screening program for cystic fibrosis (2016-2020). 295
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|